These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17410428)

  • 21. Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.
    Mocci E; Milne RL; Méndez-Villamil EY; Hopper JL; John EM; Andrulis IL; Chung WK; Daly M; Buys SS; Malats N; Goldgar DE
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):803-11. PubMed ID: 23456555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family history of breast cancer as a predictor for fatal prostate cancer.
    Rodríguez C; Calle EE; Tatham LM; Wingo PA; Miracle-McMahill HL; Thun MJ; Heath CW
    Epidemiology; 1998 Sep; 9(5):525-9. PubMed ID: 9730031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.
    Lorenzo Bermejo J; Hemminki K
    Ann Oncol; 2004 Dec; 15(12):1834-41. PubMed ID: 15550590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
    Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA
    JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial breast cancer].
    Fukutomi T; Inoue R; Ushijima T; Toyoda M
    Nihon Rinsho; 1995 Nov; 53(11):2764-8. PubMed ID: 8538041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation.
    Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Kładny J; Załuga E; Fiedorowicz J; Debniak B; Lubiński J
    Eur J Cancer Prev; 2003 Jun; 12(3):241-5. PubMed ID: 12771565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
    Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
    Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.
    Marchina E; Fontana MG; Speziani M; Salvi A; Ricca G; Di Lorenzo D; Gervasi M; Caimi L; Barlati S
    Oncol Rep; 2010 Dec; 24(6):1661-7. PubMed ID: 21042765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascertainment and anticipation in family studies.
    Hoh J; Heitjan DF; Mérette C; Ott J
    Hum Hered; 2001; 51(1-2):23-6. PubMed ID: 11096267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of the effect of nongenetic risk factors on the familial risk of breast cancer among relatives of postmenopausal breast cancer patients.
    Chen PL; Sellers TA; Rich SS; Potter JD; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1994; 3(7):549-55. PubMed ID: 7827584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of age of onset in pancreatic cancer kindreds.
    Brune KA; Lau B; Palmisano E; Canto M; Goggins MG; Hruban RH; Klein AP
    J Natl Cancer Inst; 2010 Jan; 102(2):119-26. PubMed ID: 20068195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.
    Larsen MJ; Thomassen M; Tan Q; Lænkholm AV; Bak M; Sørensen KP; Andersen MK; Kruse TA; Gerdes AM
    BMC Med Genomics; 2014 Jan; 7():9. PubMed ID: 24479546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
    Levin AM; Zuhlke KA; Ray AM; Cooney KA; Douglas JA
    Prostate; 2007 Oct; 67(14):1507-13. PubMed ID: 17683075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
    Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
    Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semiparametric estimation of major gene and family-specific random effects for age of onset.
    Li H; Thompson E
    Biometrics; 1997 Mar; 53(1):282-93. PubMed ID: 9147596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Logistic regression of family data from retrospective study designs.
    Whittemore AS; Halpern J
    Genet Epidemiol; 2003 Nov; 25(3):177-89. PubMed ID: 14557986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial aggregation of breast/ovarian cancer: age of onset along subsequent generations in Brazil.
    Koifman RJ; Koifman S; Vieira RJ
    Cad Saude Publica; 1998; 14 Suppl 3():181-5. PubMed ID: 9819477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.